An increase in C-Reactive Protein (CRP) levels, a non-specific marker for systemic inflammation, is associated with severe CRS and may serve as an indicator of poor treatment outcome (25, 26, 28, 29). This evidence concerns the gene CRP and congenital rubella syndrome.